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This retrospective study details 94 patients after
surgical resection of carcinoma of the ampulla of
Vater to determine prognostic factors. The tumour
was limited to the ampulla of Vater in 32%, invaded
the duodenal wall in 34%, infiltrated 2cm or less
into the pancreas in 22%, and invaded more than
2cm into the pancreas and/or other adjacent struc-
tures in 11%. Curative resection was accomplished
in 97% of cases. After exclusion of perioperative
deaths the 1-, 5- and 10-year survival rates were
79.6%, 38.2%, and 31.6%, respectively with a median
survival of 3.68 years. 26 patients survived more than
five and 15 patients more than ten years. In an
univariate analysis advanced tumour size, poor
tumour grading, lymph node metastases and ad-
vanced UICC stage significantly decreased survival.
Comparison of short and long survivors confirmed
tumour size, lymph node status and UICC stage as
significant prognostic factors. In a multivariate
analysis (Cox model), only tumour size was a
statistically independent predictor of prognosis.
The survival probability increased with each year a
patient survived after resection. When a patient had
already survived five years after resection, the
probability to survive another five years was 83%.
Careful clinicopathologic staging is important for
the prognosis after resection.
Keywords: Ampullary carcinoma, ampullary neoplasms
pathology, ampullary neoplasms surgery, prognostic factors,
long-term prognosis
INTRODUCTION
The prognosis of patients with malignant tu-
mours is influenced by factors which can be
categorised into patient-, tumour-, and treat-
ment-associated factors [1]. In the present article,
an effort is made to evaluate the prognostic
significance of various clinicopathologic factors
after surgical resection of ampullary carcinoma.
The results of such analyses form the basis of a
rational and pragmatic surgical treatment. Iden-
tification of prognostic factors will help to
identify patients who have the chance of long-
term survival and others who are at risk for an
early tumour recurrence. The results of these
statistical methods are fundamentally influenced
by the chosen test variables and the method of
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analysis. The majority of patients die within the
first five years after resection and little is known
about late survival of patients after surgery, for
carcinoma of the ampulla of Vater. In addition, it
has been suggested that 5 year survival rates
might underestimate the possibilities of later
recurrence and death, making the real benefits of
surgery doubtful. Thus, it appeared of interest to
undertake a specific study of patients who
underwent resection of ampullary cancer more
than five and ten years ago to determine "who"
are the long-term survivors after a resection of
ampullary carcinoma. Within such a cohort of
long-term surviving cancer patients one can
identify those factors that are associated with
either the absence or presence of long-term
survival. A subtle analysis of the patient’s
individual situation contributes to an improved
prognostic evaluation and grouping.
PATIENTS, MATERIALS AND METHODS
Patients Selection
At Hannover Medical School a total of 94
consecutive patients underwent resection of
carcinoma of the ampulla of Vater between
January 1971 and December 1995.
Evaluation of Clinicopathological Data
Pathologic and operative notes were carefully
reviewed to exclude any patient with a tumour
arising from the duodenum, the intrapancreatic
distal bile duct, the exocrine pancreatic tissue or
the endocrine pancreas. In all 94 patients the
resected specimens have been kept and were
reanalysed for tumour grading. Tumour node
metastasis (pTNM) staging was performed
according to the staging system jointly devel-
oped by the American Joint Committee on
Cancer (AJCC) and the International Union
Against Cancer (UICC) [2]. The residual tumour
(R) classification was used to define the absence
or presence of residual tumour after resection.
R1 represents microscopic, R2 macroscopic, and
R0 no residual tumour. Tumour differentiation
was determined using the UICC grading system,
evaluating H and E stained sections of at least
five tissue blocks per tumour sample. In our
patients adjuvant chemotherapy was only ap-
plied in four patients, but without a standar-
dised regimen of adjuvant or multimodal
treatment.
Data Collection
Data concerning patient, clinical and pathologic
tumour characteristics, treatment modalities and
their results were collected from medical re-
cords. Follow-up data were obtained by patient
interview, letters, hospital charts, and personal
contact with the attending physician. For survi-
vors the attending physician was asked to fill
out a standardized questionaire. Complete in-
formation about the survival status could be
obtained for all patients. Follow-up data were
available as from 1 April 1996. Operative
mortality was calculated as death before hospital
discharge.
Statistical Analysis
Statistical analysis was performed using the chi-
square (X2) test with the probability level set to
p _< 0.05. Patient survival was calculated by t-he
method of Kaplan and Meier [3]. The prognostic
significance of each clinicopathological variable
was calculated after exclusion of hospital mor-
tality. The relationship between each of the
variables and survival was assessed by the log
rank test (Mantel-Cox) [4]. A value of p _< 0.05
was considered to be statistically significant. A
multivariate analysis was performed using
Cox’s proportional hazards regression [5]. Only
the variables that were statistically significant by
univariate analysis were included in a multi-
variate analysis to establish a hierarchy among
the various prognostic factors. The stability ofLONG-TERM SURVIVAL OF AMPULLARY CANCER 3
the model was certified by using a likelihood
ratio step-forward and step-backward fitting
procedure. The level of significance was taken
from the last step of the regression analysis. A
value of p < 0.05 was considered to be statisti-
cally significant.
Histopathological slides a.nd resected speci-
mens were reviewed to confirm the diagnosis and
to study the following pathological features with
potential prognostic influence: size and grading
of the tumour, nodal status and margin, tumor
localisation, distant metastases, vascular inva-
sion, microscopic involvement of perineural
spaces, and lymphatic and blood vessels. Other
determinants analysed included age, sex, type of
resection, radicality of operation, clinical symp-
toms (jaundice, diabetes mellitus, upper abdom-
inal pain, back pain, etc.), intra- and postoperative
blood transfusions, postoperative complications,
and extended vascular and organ resection.
these patients pylorus preserving Whipple’s
procedure was applied. Pancreatic reconstruc-
tion comprised pancreatojejunostomy in 84%
and pancreogastrostomy in 16%. Three patients
underwent total pancreatectomy. Intra, and/or
postoperative blood transfusions were given in
84% of patients.
Operative Mortality
Inhospital mortality was 9.6% (9 of 94) in the
entire time period. In the last decade mortality
amounted to 5.6%. Causes of death were septic
multiorgan failure in all but one patient who
died from massive bleeding. The underlying
problem was insufficiency of the pancreatic
anastomosis in 4 and of the biliodigestive
anastomosis in one patient. Relaparotomy be-
cause of postoperative complications was neces-
sary in 26%.
RESULTS
Patient Characteristics
There were 56 males (60%) and 38 females (40%)
aged 34 to 82 years (median 63.1-t-11.4 years).
Clinical Presentation
The presenting clinical symptoms were painless
jaundice (60%), upper abdominal pain (37%),
weight loss (35%), weakness (13%), loss of
appetite (11%), and back pain (5%). Acute and
chronic pancreatitis were noted in 6% and 4%,
resp. Eight patients had a previous history of
malignancy. The diagnosis was established by
ultrasonography, computed tomography, endo-
scopy, and endoscopic retrograde cholangiogra-
phy. Biopsies were not regularly taken.
Surgical Procedures
Turnout removal was accomplished by partial
duodenopancreatectomy in 91 cases. In 3 of
pTNM Staging and Tumour Grading
The tumour was limited to the ampulla of Vater
in 32% (pT1), invaded the duodenal wall in 34%
(pT2), infiltrated 2cm or less into the pancreas
in 22% (pT3), and invaded more than 2cm into
the pancreas and/or other adjacent structures in
11% (pT4). Regional lymph node involvement
was found in 38%. There was a direct correlation
between tumour size and lymph node status.
Distant metastases were present only in one
patient. Despite multiple small liver metastases
a Whipple’s operation was performed. Residual
adenoma was found in a total of 8 of 94 (8.5%) of
regected carcinomas. In 21 patients since 1991
the number of resected lymph nodes in the
resected specimens was determined and
amounted to a mean of 12.5+1. In nodal
positive patients an average of 39: 8% of the
removed lymph nodes were affected.
According to the UICC the one patient with a
tumour in situ was classified as stage 0. Twenty-
six percent of patients were grouped into stage
II, 30% in stage III, and 12% in stage IV.4 J. KLEMPNAUER et al.
In all cases an adenocarcinoma arose from the
mucosa of the ampulla of Vater. Tumour
grading was possible in all but six cases.
Tumour was well (G1) in 40%, moderate (G2)
in 49%, poorly differentiated (G3) in 10%, and
undifferentiated (G4)in 1%.
Residual Tumour Stage
Curative R0 resection was possible in all but
three patients (97%). Microscopic tumour was
left behind (R1 resection) at the pancreatic
resection margin in two patients. Hepatic me-
tastases were not resected in one patient (R2
resection).
Long-term Survival and Tumour Recurrence
Overall survival including hospital deaths was
34.5% at 5 and 28.6% at 10 years. After exclusion
of hospital mortality the respective figures were
38.2% at 5 and 31.6% at 10 years. The median
survival time after exclusion of hospital deaths
was 3.684-0.88 years. 26 patients actually sur-
vived for more than 5 and 15 for more than 10
years. Table I lists the clinicopathological factors
of the 15 patients surviving more than ten years
after curative resection of ampullary cancer in
chronological sequence. The majority of these
(8/15) is still alive with no evidence of disease.
To our knowledge none of the remaining 7
patients died from tumour recurrence.
Table II lists a comparison of clinicopatholo-
gical factors in patients who died prior to the
median survival time or who survived beyond
this time. Significant differences were noted for
tumour size and UICC stage. Lymph node
metastases were not significant (p=0.0628),
neither were age, gender, partial vs. total
pancreatectomy, blood transfusions, and post-
operative requirement for a relaparotomy.
Figure 1 shows the development of the five
year survival probability for patients who have
already survived various time intervals after
resection of ampullary carcinoma. The chance to
survive another 5 years increased with each year
after resection. When a patient had already
survived five years after resection the chance
to survive another five year period was 83%.
Uni- and Multivariate Analysis
Table III shows the clinicopathological para-
meters investigated in the univariate survival
TABLE Clinicopathological factors in patients surviving ten years or longer after curative resection of ampullary carcinoma
in chronological sequence
Operation Age Gender pTNM UICC- Grading Survival Outcome
date stage (years)
11/72 35.8 T1 NO M0 GX 16.6 died from breast
cancer
4/76 66.2 T2 NO M0 II G1 19.9 alive, NED
2/77 56.0 m T3 NO M0 II G3 17.4 dead
2/77 61.4 m T2 NO M0 II GX 11.4 dead
10/78 67.6 m T2 NO M0 II G1 17.3 alive, NED
8/80 50.7 T1 NO M0 G1 15.5 alive, NED
9/81 73.7 m T1 NO M0 G1 12.8 dead, NED
9/81 58.4 T2 N1 M0 III G2 14.5 dead, NED
11/81 69.6 T1 NO M0 G1 13.4 dead, NED
9/83 72.4 T2 N1 M0 III G1 10.2 dead, NED
11/83 60.9 m T3 N1 M0 III G2 12.3 alive, NED
4/84 51.3 m T2 N1 M0 III G1 11.9 alive, NED
8/84 40.1 m T1 NO M0 G1 11.5 alive, NED
10/84 65.8 T1 NO M0 GX 11.3 alive, NED
11 /85 40.9 m T2 NO M0 II G3 10.3 alive, NED
NED: no evidence of disease.LONG-TERM SURVIVAL OF AMPULLARY CANCER 5
TABLE II Comparison of clinicopathologic factors between patients who died prior to the median survival time of the entire
group (3.68 years) and patients who survived beyond this time years
Factor Early deaths Long survivors x2-test
(n=39) (n=36)
Tumour size 0.0107
pTis (3) 0 (0)
pT1 8 (21) 13 (36)
pT2 8 (21) 16 (44)
pT3 15 (38) 6 (17)
pT4 7 (18) (3)
Lymph node metastasis 0.0628
pN0 20 (51) 26 (72)
pN1 19 (49) 10 (28)
Distant metastasis
M0 38 (97) 36 (100)
pM1 1 (3) 0 (0)
UICC stage 0.0436
Stage 0 (3) 0 (0)
Stage 7 (18) 11 (31)
Stage II 9 (23) 15 (42)
Stage III 14 (36) 9 (25)
Stage IV 8 (21) (3)
Residual tumour stage
R0 37 (95) 36 (100)
R1 (3) 0 (0)
R2 (3) 0 (0)
Tumour grading 0.3581
well differentiated (G1) 12 (32) 16
moderately differentiated (G2) 20 (54) 12
poorly differentiated (G3) 4 (11) 4
undifferentiated (G4) (3) 0 (0)
Preoperative jaundice 0.2054
Present 28 (76) 21 (62)
Absent 9 (24) 13 (38)
Values in parentheses are percentages. Analysis excluded hospital mortality. Only complete data were taken into account. *statistical analysis not
performed, because of too few patients.
analysis. Tumour size, lymph node metastases,
UICC stage and grading had a significant impact
on long term survival. The Kaplan-Meier
survival plots for the different tumour sizes are
depicted in Figure 2. No statistical significance
for survival was attached to age, gender, type of
resection, blood transfusions, postoperative
complications requiring relaparotomy and the
presence of preoperative jaundice. Distant me-
tastases and residual tumour stage were not
tested because of too few patients.
In the multivariate analysis only tumour size
was of independent prognostic significance
X
2 12.89, p 0.0118).
DISCUSSION
The objective of this study was to identify
determinants of long-term survival after resec-
tion of ampullary carcinoma. Our retrospective
single centre analysis comprised 94 patients who
all had tumours arising in the mucosa of the
ampulla of Vater. In the literature, the histoge-
netic origin of periampullary tumours is not
always clearly defined [6]. Ampullary, distal bile
duct, duodenal, and pancreatic carcinoma have
to be distinguished [7]. An accurate pathologic
confirmation of the tumour type and anatomic
origin is essential when reporting survivial rates6 J. KLEMPNAUER et al.
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FIGURE Development of the five year survival prob-
ability for patients who have already survived various time
intervals after resection of carcinoma of the ampulla of
Vater.
and factors for prognostic grouping for ampul-
lary carcinoma [1]. There is a close relationship
between adenoma and adenocarcinoma of the
ampulla of Vater. In our series coexisting
adenoma was found in 8.5%. Adenomas of the
.ampulla of Vater are not encountered so
frequently as those in the colon and rectum,
but an ampullary adenocarcinoma can arise
from a pre-existing adenoma, in the same
location [8, 9].
There has been a considerable debate whether
there is a place for local excision of ampullary
carcinomas [10-12]. Theoretically, local resec-
tion is only applicable for stage 0 and I tumours.
Pre- and intraoperatively, however, it cannot be
precisely determined whether the tumour is
limited to the ampulla of Vater itself or whether
TABLE III Univariate survival analysis according to clinicopathological parameters
Factor n 5 year survival 10 year survival p
(%) (%) (log rank)
Tumour size
pTis
pT1
pT2
pT3
pT4
Lymph node metastasis
pN0
pN1
Distant metastasis
M0
pM1
UICC stage
Stage 0
Stage
Stage II
Stage III
Stage IV
Residual tumour stage
R0
R1
Tumour grading
well differentiated (G1)
died after 2.5 yrs
25 56.0 43.6
29 50.6 45.5
21 14.3 9.5
9 22.2 0
53 44.9 36.8
32 27.2 22.6
84 38.7 32.0
died after 0.4 yrs
died after 2.5 yrs
22 58.1 49.8
26 40.8 31.7
26 29.7 23.8
10 20.0 0
83 39.1 32.4
died after 0.2 yrs
died after 0.4 yrs
29
moderately differentiated (G2) 40
poorly differentiated (G3) 9
undifferentiated (G4)
Preoperative jaundice
Present 53 35.5
Absent 28 40.8
Analysis excluded hospital mortality. Only complete data were taken into account.
*statistical analysis not performed, because of too few patients.
46.9 43.0
26.3 16.4
51.9 38.9
died after 0.4 yrs
27.9
35.7
0.0057
0.0162
0.0488
< 0.0001
0.4283LONG-TERM SURVIVAL OF AMPULLARY CANCER 7
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FIGURE 2 KaplanlMeier survival according to tumour size
(log rank test, p=0.0024). Hospital mortality excluded. Tick
mark indicates last follow-up.
it infiltrates adjacent structures. Mucosal spread
or interstitial infiltration was frequently found
even in cases with carcinoma at a relatively early
stage [13]. Final tumour staging is only possible
after definitive histopathological examination of
the resected specimen. Thus, pancreatoduode-
nectomy should be the treatment of choice for all
carcinomas of the ampulla of Vater [14-19].
During duodenopancreatectomy the pancreas is
transsected at the left border of the mesenter-
icoportal vein. In our view a systematic and
radical lymphadenectomy is obligatory. The
pylorus-preserving modification of Whipple’s
operation has been advocated for resection of
ampullary carcinomas [20, 21]. Advantages of
pylorus preservation are a more physiologic
alimentary reconstruction and the fact that there
is no reflux of bile into the stomach. It has to be
assured, however, that the extent of lymphade-
nectomy is not impaired [21]. Lymph node
involvement around the stomach is very rare
in carcinoma of the ampulla of Vater [21, 22].
There is a considerable mortality and morbid-
ity of local resection, which may exceed that of
Whipple’s procedure [10, 11]. Hospital mortality
rate after pancreatic resection decreased in the
present series, from more than 20 per cent in the
earlier period to about 5 per cent in the later
period. The operative mortality rate could be
dramatically reduced in all centres dealing with
pancreatic surgery, and some authors have
reported a large number of pancreatic resections
without deaths [19, 23, 24]. We have excluded
the postoperative mortality from the uni- and
multivariate factorial analyses. The inclusion of
postoperative deaths makes the direct compar-
ison of results dubious, because otherwise
hospital mortality would be a primary prognos-
tic factor.
In order to characterise the prognostic factors
of ampullary cancer we have used three differ-
ent approaches namely uni- and multivariate
analysis, comparison between short and long-
term survivors and evaluation of patients who
actually survived 10 years after resection. Uni-
and multivariate analyses identify various prog-
nostic factors after resectional therapy of ampul-
lary carcinoma and provide more reliable
information than that obtained only through
clinical experience or simple statistical analysis.
Regression analyses clarify the extent to which
each factor has statistical independence. Because
of the fact, that the majority of patients dies
within the first few years after surgical tumour
resection, it is important to analyse determinants
of long-term survival. We have thus compared
the clinicopathological factors of patients who
died prior and after the median survival time of
the entire group. It was of interest to evaluate
patients who actually survived for prolonged
periods of time, since one and 5 year survival
rates underestimate the possibilities of later
recurrence and death.
The only independent prognostic factor de-
rived from multivariate Cox proportional ha-
zard regression was tumour size. Tumour size
was not measured as actual diameter in centi-
metres. The qualitative definition of the UICC
was employed which considers the depth of
local invasion. Tumours limited to the ampulla
of Vater had an excellent prognosis. Even when
the tumour directly invaded the duodenal wall,8 J. KLEMPNAUER et al.
more than 40% of patients were still alive at 10
years after surgery. The prognosis was markedly
impaired when the tumour had invaded the
pancreas and/or other adjacent structures. Be-
sides tumour size other factors of prognostic
significance were lymph node status, grading,
and the UICC stage. These factors, however, had
no independent influence on prognosis when
integrated in the regression analysis and proved
to be significant only in the univariate approach.
With respect to the lymph node status the lack
of significance in the multivariate analysis can
be partially attributed to the fact, that patients
with advanced tumour size also had a higher
proportion of positive lymph nodes. In the
univariate approach positive lymph nodes at
the time of resection were clearly associated
with an impaired prognosis. These findings are
in accordance with data from the literature [25].
In all cases a systematic and radical lymphade-
nectomy was performed in our patients. From
our data it cannot be delineated whether such a
lymphadenectomy has a beneficial effect on
prognosis. Removal of regional lymph nodes,
however, is absolutely mandatory for an ade-
quate tumour staging.
A high degree of tumour differentiation was
also significantly correlated with a more favour-
able prognosis in the uni- but not the multi-
variate regression analysis. The prognostic
relevance of tumour grading after resection of
ampullary cancer is not surprising. It is also a
feature of ductal pancreatic carcinoma and other
gastrointestinal adenocarcinomas.
The UICC staging system has the deliberate
objective to predict the individual patient’s
prognosis at the time of resection. Unfortu-
nately, this staging system proved to be only of
limited value after resection of ampullary
carcinoma. From our retrospective analysis this
is mainly related to an overemphasis in the
UICC classification of the lymph node status
over tumour size. In our opinion, however,
tumour size is more important than lymph node
status. In particular, stage II comprises both
nodally negative pT2 and pT3 tumours. Our
data show, that direct infiltration of ampullary
tumours into the pancreas was associated with a
dramatically impaired prognosis, whereas infil-
tration of the duodenum did not decrease the
survival probability in comparison to pT1
tumours which are limited to the ampulla of
Vater itself. Furthermore, the UICC places
patients with positive lymph nodes generally
in stage III and does not further distinguish
between pT1, pT2 and pT3 tumours. In a smaller
group of 36 patients Sperti et al., identified
tumour stage, lymph node involvement and
tumour differentiation as prognostic factors but
only in a univariate analysis [26].
It seems evident that distant metastases and
non-curative resections also have a negative
impact on prognosis. In our analyses, these
two factors did not prove to be significant
simply because of a too small number of patients
involved. Diffuse small liver metastases were
left behind during a Whipple’s operation and
the patient died after 0.4 years. Non-curative
resection with infiltration of the pancreatic
resection margin in two patients was also
associated with very short survival of only a
few months.
Our analysis also revealed factors which had
no effect on prognosis after resection of ampul-
lary cancer e.g., age and sex, blood transfusions,
surgical complications, and preoperative jaun-
dice. Age should not be a contraindication to
resection. Perioperative blood transfusion has
been identified as a negative prognostic factor in
a number of solid tumours [27-29]. Cameron
et al., noted that patients receiving more than 2
units of blood in the perioperative period after
resection for pancreatic cancer had a signifi-
cantly worse prognosis, with transfusion prov-
ing to be an independent prognostic factor [30].
In our opinion, however, the adverse influence
of blood transfusion may well be the result of a
correlation with other prognostic variables, since
transfused patients are very often those who
present with poorer performance status, withLONG-TERM SURVIVAL OF AMPULLARY CANCER 9
TABLE IV Published results of resection in patients with carcinoma of the ampulla of Vater
Author Year of Patient no. Mortality
publication rate
Survival
Wise et al. *[34]
Tarazi et al. [35]
Yamaguchi and Enjoji [9]
Neoptolemos et al. [36]
Dawson and Connolly [37]
Mori et al. [38]
Monson et al. [39]
Bakkevold and Kambestad [40]
Willett et al. [41]
Matory et al. [42]
Sperti et al. [26]
Andersen et al. [43]
Nakao et al. [44]
Roder et al. [25]
Chan et al. [45]
Futakawa et al. [13]
present study
1976 2390 18.8%
1986 105 7.8%
1987 109 6%
1988 23 NA
1989 24 12.5%
1990 24 8.3%
1991 104 5.7%
1993 30 NA
1993 41 4.9%
1993 55 3.6%
1994 36 2.8%
1994 25 NA
1994 26 0%
1995 66 4.5%
1995 29 NA
1996 60 NA
1996 94 9.6%
29.3%
37.2%
28%
52.1%
29%
50.2%
34%
15%
55%
43.0%
56%
34%
52%
35%
43%
NA
38.2%
NA not available; *collected series; tmulticenter study.
more advanced and rapidly spreading diseases
and/or undergo more problematic surgery.
Randomised prospective studies, encompassing
a score of problems faced during surgery, and a
well-defined policy of blood transfusion in the
post-operative period will further highlight this
topic. In our series adequate management of
complications did not impair long-term prog-
nosis. Our experience could not confirm that
non-icteric ampullary carcinoma have a more
favourable prognosis [31]. About 30% of patients
with ampullary carcinomas are not icteric at time
of diagnosis [31, 32].
The prognosis after resection of ampullary
carcinoma is excellent especially when com-
pared to ductal pancreatic cancer [33]. In this
respect our study confirms the results reported
from many other centers (Tab. IV). We would
like to speculate that a considerable number of
patients are actually cured from ampullary
carcinoma by surgical resection. Our experience
is that patients who have survived five years
and more have a life expectancy which resem-
bles that of a normal population. Other authors
have pointed out that five-year survival offered
no guarantee of cure. Trede et al. [23] noted that
5 of his 21 patients with 5 year survivial
subsequently died of their cancer, and Monson
et al., reported that 8 of 20 patients surviving 5
years after resection died of tumour recurrence
[39]. Characterisation of long-term survivors
after surgery for cancer of the ampulla of Vater
is particularly useful to better define the selec-
tion criteria for treatment. It is essential to define
patients who have a high risk to die early after
resection. This subgroup might benefit from
adjuvant multimodal cancer treatment including
chemo- and or radiotherapy. In patients with a
good chance of long survival, surgical resection
might suffice alone and additional chemo- and
radiotherapy would be overtreatment.
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COMMENTARY
This retrospective review of one unit’s experience
with the treatment of carcinoma of the ampulla of
Vater provides important information to guide us
in our treatment strategies for this disease. The
authors are in the unique position of having
access to detailed pathologic records and speci-
mens of all patients who underwent resectional
surgery since 1971. Furthermore theywere able to
correlate the pathologic data with patient survival
in all 94 patients consecutively treated in the one
institution. The results were not surprising but
give the following strong messages; Major pan-
creatic surgery performed in experienced units is
associated with an acceptably low operative
mortality consequently resectional surgery for
attempted cure should be considered for all
patients with this disease. Patients with ampul-
lary carcinoma can be cured following surgical
resection. Cure and long term survival is depen-
dent on the tumour characteristics such as depth
of local invasion, tumour grading and lymph
node metastases.
Preoperative assessment of the tumour related
prognostic factors may now be possible with
advances in endoscopic and laparoscopic ultra-
sound techniques [1]. Recent studies have
shown that endoscopic ultrasonography can
quite accurately determine the depth of invasion
of ampullary tumours and may provide infor-
mation that can be used in determining the type
of therapy to be recommended [2]. For instance
if ultrasonography determines that the tumour
is confined to the mucosa it may be appropriate
to limit the surgery to local resection.
Preoperative laparoscopic assessment and la-
paroscopic ultrasonography has been shown to
detect with high accuracylymph node metastases
and spread to the liver [3]. Survival of these
patients is not prolonged by major resectional
surgery consequently these minimal access tech-
niques have been used in order to exclude
patients who will not benefit from major surgery.
The results of the study by Klempnauer et al.,
provides the pathologic and survival data on
which assessment of ultrasonographic staging
may be based.
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